401907-26-4,MFCD29770787
Catalog No.:AA00CNEL

401907-26-4 | JYL1421

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
DMSO
in stock  
$120.00   $84.00
- +
5mg
98%
in stock  
$399.00   $279.00
- +
10mg
≥95%
in stock  
$610.00   $427.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00CNEL
Chemical Name:
JYL1421
CAS Number:
401907-26-4
Molecular Formula:
C20H26FN3O2S2
Molecular Weight:
423.5677
MDL Number:
MFCD29770787
SMILES:
S=C(NCc1ccc(cc1)C(C)(C)C)NCc1ccc(c(c1)F)NS(=O)(=O)C
Properties
Computed Properties
 
Complexity:
608  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
28  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0  
Rotatable Bond Count:
7  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
3.7  

Literature

Title: 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent transient receptor potential vanilloid 1 (TRPV1) antagonists: structure-activity relationships of 2-amino derivatives in the N-(6-trifluoromethylpyridin-3-ylmethyl) C-region.

Journal: Journal of medicinal chemistry 20121011

Title: N-4-t-Butylbenzyl 2-(4-methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure-activity relationships in the A-region.

Journal: Bioorganic & medicinal chemistry 20120101

Title: The chimeric approach reveals that differences in the TRPV1 pore domain determine species-specific sensitivity to block of heat activation.

Journal: The Journal of biological chemistry 20111111

Title: TRPV1 activation is required for hypertonicity-stimulated inflammatory cytokine release in human corneal epithelial cells.

Journal: Investigative ophthalmology & visual science 20110101

Title: Silicon switch approach in TRPV1 antagonist MK-056 and its analogues.

Journal: Bioorganic & medicinal chemistry 20100101

Title: Selective pharmacological blockade of the TRPV1 receptor suppresses sensory reflexes of the rodent bladder.

Journal: The Journal of urology 20090801

Title: Differential effects of transient receptor vanilloid one (TRPV1) antagonists in acid-induced excitation of esophageal vagal afferent fibers of rats.

Journal: Neuroscience 20090630

Title: Design, synthesis, and biological evaluation of novel diarylalkyl amides as TRPV1 antagonists.

Journal: Bioorganic & medicinal chemistry 20090515

Title: The role of transient receptor potential vanilloid 1 in mechanical and chemical visceral hyperalgesia following experimental colitis.

Journal: Neuroscience 20070921

Title: Alpha-substituted N-(4-tert-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as potent and stereospecific TRPV1 antagonists.

Journal: Bioorganic & medicinal chemistry 20070915

Title: The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20070328

Title: Analysis of structure-activity relationships for the 'B-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]-thiourea analogues as TRPV1 antagonists.

Journal: Bioorganic & medicinal chemistry letters 20050915

Title: Analysis of structure-activity relationships for the 'A-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as TRPV1 antagonists.

Journal: Bioorganic & medicinal chemistry letters 20050915

Title: Novel potent antagonists of transient receptor potential channel, vanilloid subfamily member 1: structure-activity relationship of 1,3-diarylalkyl thioureas possessing new vanilloid equivalents.

Journal: Journal of medicinal chemistry 20050908

Title: Pharmacological characterization of the TRPV1 receptor antagonist JYL1421 (SC0030) in vitro and in vivo in the rat.

Journal: European journal of pharmacology 20050704

Title: Vanilloid receptor TRPV1 antagonists as the next generation of painkillers. Are we putting the cart before the horse?

Journal: Journal of medicinal chemistry 20040520

Title: N-4-methansulfonamidobenzyl-N'-2-substituted-4-tert-butyl-benzyl thioureas as potent vanilloid receptor antagonistic ligands.

Journal: Bioorganic & medicinal chemistry letters 20040405

Title: Novel non-vanilloid VR1 antagonist of high analgesic effects and its structural requirement for VR1 antagonistic effects.

Journal: Bioorganic & medicinal chemistry letters 20031215

Title: High affinity antagonists of the vanilloid receptor.

Journal: Molecular pharmacology 20021001

Title: Jakab B, et al. Pharmacological characterization of the TRPV1 receptor antagonist JYL1421 (SC0030) in vitro and in vivo in the rat. Eur J Pharmacol. 2005 Jul 4;517(1-2):35-44.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 401907-26-4
Tags:401907-26-4 Molecular Formula|401907-26-4 MDL|401907-26-4 SMILES|401907-26-4 JYL1421
Catalog No.: AA00CNEL
401907-26-4,MFCD29770787
401907-26-4 | JYL1421
Pack Size: 1mg
Purity: DMSO
in stock
$120.00 $84.00
Pack Size: 5mg
Purity: 98%
in stock
$399.00 $279.00
Pack Size: 10mg
Purity: ≥95%
in stock
$610.00 $427.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00CNEL
Chemical Name: JYL1421
CAS Number: 401907-26-4
Molecular Formula: C20H26FN3O2S2
Molecular Weight: 423.5677
MDL Number: MFCD29770787
SMILES: S=C(NCc1ccc(cc1)C(C)(C)C)NCc1ccc(c(c1)F)NS(=O)(=O)C
Properties
Complexity: 608  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 28  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 3  
Isotope Atom Count: 0  
Rotatable Bond Count: 7  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 3.7  
Literature fold

Title: 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent transient receptor potential vanilloid 1 (TRPV1) antagonists: structure-activity relationships of 2-amino derivatives in the N-(6-trifluoromethylpyridin-3-ylmethyl) C-region.

Journal: Journal of medicinal chemistry20121011

Title: N-4-t-Butylbenzyl 2-(4-methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure-activity relationships in the A-region.

Journal: Bioorganic & medicinal chemistry20120101

Title: The chimeric approach reveals that differences in the TRPV1 pore domain determine species-specific sensitivity to block of heat activation.

Journal: The Journal of biological chemistry20111111

Title: TRPV1 activation is required for hypertonicity-stimulated inflammatory cytokine release in human corneal epithelial cells.

Journal: Investigative ophthalmology & visual science20110101

Title: Silicon switch approach in TRPV1 antagonist MK-056 and its analogues.

Journal: Bioorganic & medicinal chemistry20100101

Title: Selective pharmacological blockade of the TRPV1 receptor suppresses sensory reflexes of the rodent bladder.

Journal: The Journal of urology20090801

Title: Differential effects of transient receptor vanilloid one (TRPV1) antagonists in acid-induced excitation of esophageal vagal afferent fibers of rats.

Journal: Neuroscience20090630

Title: Design, synthesis, and biological evaluation of novel diarylalkyl amides as TRPV1 antagonists.

Journal: Bioorganic & medicinal chemistry20090515

Title: The role of transient receptor potential vanilloid 1 in mechanical and chemical visceral hyperalgesia following experimental colitis.

Journal: Neuroscience20070921

Title: Alpha-substituted N-(4-tert-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as potent and stereospecific TRPV1 antagonists.

Journal: Bioorganic & medicinal chemistry20070915

Title: The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience20070328

Title: Analysis of structure-activity relationships for the 'B-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]-thiourea analogues as TRPV1 antagonists.

Journal: Bioorganic & medicinal chemistry letters20050915

Title: Analysis of structure-activity relationships for the 'A-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as TRPV1 antagonists.

Journal: Bioorganic & medicinal chemistry letters20050915

Title: Novel potent antagonists of transient receptor potential channel, vanilloid subfamily member 1: structure-activity relationship of 1,3-diarylalkyl thioureas possessing new vanilloid equivalents.

Journal: Journal of medicinal chemistry20050908

Title: Pharmacological characterization of the TRPV1 receptor antagonist JYL1421 (SC0030) in vitro and in vivo in the rat.

Journal: European journal of pharmacology20050704

Title: Vanilloid receptor TRPV1 antagonists as the next generation of painkillers. Are we putting the cart before the horse?

Journal: Journal of medicinal chemistry20040520

Title: N-4-methansulfonamidobenzyl-N'-2-substituted-4-tert-butyl-benzyl thioureas as potent vanilloid receptor antagonistic ligands.

Journal: Bioorganic & medicinal chemistry letters20040405

Title: Novel non-vanilloid VR1 antagonist of high analgesic effects and its structural requirement for VR1 antagonistic effects.

Journal: Bioorganic & medicinal chemistry letters20031215

Title: High affinity antagonists of the vanilloid receptor.

Journal: Molecular pharmacology20021001

Title: Jakab B, et al. Pharmacological characterization of the TRPV1 receptor antagonist JYL1421 (SC0030) in vitro and in vivo in the rat. Eur J Pharmacol. 2005 Jul 4;517(1-2):35-44.

Building Blocks More >
3717-17-7
3717-17-7
Benzaldehyde, 4-(1-methylethyl)-, oxime, (E)- (9CI)
AA00COKD | MFCD01070636
392741-26-3
392741-26-3
3-Chloro-n-(2,4-difluorophenyl)propanamide
AA00CQSU | MFCD01213653
39221-60-8
39221-60-8
2-Bromo-n,n-dimethylbutanamide
AA00CRGB | MFCD17235599
37952-36-6
37952-36-6
3-ETHOXYPROPANOHYDRAZIDE
AA00CTSH | MFCD07187814
373-05-7
373-05-7
6-Fluorohexanoic acid
AA00CVYK | MFCD01723315
39035-14-8
39035-14-8
2-Cyano-5-nitrophenol
AA00CYAW | MFCD02258875
3776-30-5
3776-30-5
2,2,6,6-Tetrachlorocyclohexan-1-one
AA00CZXD | MFCD00019451
35577-89-0
35577-89-0
1-Tosyl-6,7-dihydro-1H-indole-4(5H)-one
AA00D248 | MFCD02186489
329794-26-5
329794-26-5
2,3-Dichloro-4-(chloromethyl)pyridine
AA00D4GF | MFCD14581655
373356-48-0
373356-48-0
4-(Piperazin-1-yl)thieno[2,3-d]pyrimidine
AA00D5G4 | MFCD00728969
Submit
© 2017 AA BLOCKS, INC. All rights reserved.